On 27 Sep 2019, Misonix, Inc. (NASDAQ:MSON) has shown a downward move of -1.66% and traded the recent trade at $166.74. The trading volume is recorded to 1206331 shares as compared to average traded volume of 1072364 shares. The stock has a 52-week highest price of $195.81 and its 52-week lowest price was called at $151.8.
Misonix, Inc. (MSON) reported recently that it completed its before reported acquisition of privately held Solsys Medical, LLC in an all-stock transaction valued at about $109M on the date previous to closing.
Solsys and its leading cellular and tissue-based wound treatment, TheraSkin, is highly complementary to Misonix’s cutting-edge ultrasonic wound debridement solution, SonicOne, providing Misonix with a large direct advanced wound care channel-to-market that will enable the Company to expand SonicOne sales, and together with TheraSkin, establish a new standard of care in the growing chronic wound care market.
Misonix, Inc price switched up 3.44% 20-Days Simple Moving Average dropped -6.13% from 50-Days Simple Moving Average and fell -2.62% from 200 Days Simple Moving Average. MSON stock’s market capitalization arrived at $ 42858017311 and total 257035000 outstanding shares. During last trade, its maximum trading price was registered $170.54 and it’s the minimum trading price was noted $165.53.